LAMA
Showing 26 - 50 of 358
COPD, COPD Exacerbation Trial in Winston-Salem (Nebulizers, Dry Powder Inhaler, Brovana)
Terminated
- COPD
- COPD Exacerbation
- Nebulizers
- +6 more
-
Winston-Salem, North CarolinaWake Forest Baptist Health
Jun 10, 2021
Meralgia Paresthetica, Femoral Neuropathy Trial in Al Jizah (muscle energy technique, conventional selected physical therapy)
Completed
- Meralgia Paresthetica
- Femoral Neuropathy
- muscle energy technique
- conventional selected physical therapy
-
Al Jīzah, Select State, EgyptLama S Mahmoud
Feb 9, 2021
Quality of Life (TRISNOOZE)
Terminated
- Chronic Obstructive Pulmonary Disease
- Trimbow
-
Ghent, East Flanders, Belgium
- +10 more
Nov 25, 2021
COVID-19, SARS-CoV-2 Trial in Indonesia, Mexico (SARS-CoV-2 mRNA Vaccine, Placebo)
Recruiting
- COVID-19
- SARS-CoV-2
- SARS-CoV-2 mRNA Vaccine
- Placebo
-
Jakarta, Indonesia
- +11 more
Nov 10, 2021
Stroke Trial in Al Jizah (Myofascial trigger points pressure (MTrP) release, Shockwave therapy application, conventional
Completed
- Stroke
- Myofascial trigger points pressure (MTrP) release
- +2 more
-
Al Jīzah, Select State, EgyptLama S Mahmoud
Nov 8, 2020
COPD Exacerbation Trial in Copenhagen (Long acting muscarinic antagonists (LAMAs) at bedtime)
Recruiting
- COPD Exacerbation
- Long acting muscarinic antagonists (LAMAs) at bedtime
-
Copenhagen, DenmarkHerlev-Gentofte Hospital
Jan 30, 2023
Bronchiectasis Adult Trial (LABA/LAMA or Placebo inhalation)
Not yet recruiting
- Bronchiectasis Adult
- LABA/LAMA or Placebo inhalation
- (no location specified)
Aug 11, 2020
COPD Trial in Chongqing (Glucocorticoids, Antibiotics, Inhaled corticosteroid (ICS))
Completed
- Chronic Obstructive Pulmonary Disease
- Glucocorticoids
- +6 more
-
Chongqing, Chongqing, ChinaDaping Hospital
Oct 22, 2020
Treatment of Obstructive Lung Diseases
Unknown status
- Chronic Obstructive Pulmonary Disease
- +2 more
- LABA + LAMA
- +4 more
-
Leuven, Vlaanderen, BelgiumUZ Gasthuisberg
Apr 7, 2020
Chronic Obstructive Pulmonary Disease Dual Therapy Burden of
Completed
- Pulmonary Disease, Chronic Obstructive
- UMEC/VI
- +5 more
-
Durham, North CarolinaGSK Investigational Site
Jul 20, 2020
Effectiveness of Triple Therapy in COPD
Completed
- Pulmonary Disease, Chronic Obstructive
- Long-acting beta2-agonist-long-acting muscarinic antagonists-inhaled corticosteroids(LABA-LAMA-ICS)
- Long-acting beta2-agonist-inhaled corticosteroids-long-acting muscarinic antagonists (LABA-LAMA)
-
London, United KingdomClinical Practice Research Datalink
Nov 29, 2019
Chronic Obstructive Pulmonary Disease (COPD) Participants
Recruiting
- Pulmonary Disease, Chronic Obstructive
- prospective observational cohort study
-
Hannover, Niedersachsen, GermanyGSK Investigational Site
Jun 20, 2022
Asthma Trial in Worldwide (CHF 5259 12.5 µg, CHF 5259 )
Completed
- Asthma
- CHF 5259 12.5 µg
- CHF 5259 placebo
-
Ruse, Bulgaria
- +27 more
Apr 6, 2021
Patterns and Patient Reported Outcome in COPD (REMIND)
Not yet recruiting
- COPD
- (no location specified)
Jun 12, 2023
Pulmonary Disease, Chronic Obstructive Trial in United States (Stiolto Respimat, ICS (Inhaled Corticosteroid) (Triple therapy),
Completed
- Pulmonary Disease, Chronic Obstructive
- Stiolto Respimat
- +3 more
-
Mobile, Alabama
- +89 more
May 24, 2022
Tiotropium and Olodaterol in Comparison to Triple Therapy
Completed
- Pulmonary Disease, Chronic Obstructive
- Tiotropium and Olodaterol (Tio+Olo)
- Long-acting beta2-agonist and Inhaled corticosteroids (LABA and ICS)
-
Andover, MassachusettsHealthCore, Inc.
Nov 12, 2021
Pulmonary Disease, Chronic Obstructive Trial in Italy (Bronchodilator Agents)
Terminated
- Pulmonary Disease, Chronic Obstructive
- Bronchodilator Agents
-
Bari, BA, Italy
- +38 more
Dec 23, 2022
COPD (COPD) Trial in Worldwide (Placebo, Tozorakimab)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease (COPD)
- Placebo
- Tozorakimab
-
Sheffield, Alabama
- +31 more
Sep 11, 2023
Enteric Hyperoxaluria Trial in New York (Moderately High Oxalate (MOx) Diet)
Recruiting
- Enteric Hyperoxaluria
- Moderately High Oxalate (MOx) Diet
-
New York, New YorkNYU Langone Health
Nov 10, 2022
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (QBW251, Placebo, COPD maintenance background therapy)
Completed
- Pulmonary Disease, Chronic Obstructive
- QBW251
- +2 more
-
Andalusia, Alabama
- +147 more
Jul 27, 2022
Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease
Completed
- Pulmonary Disease, Chronic Obstructive
- Tiotropium+Olodaterol
- +3 more
-
Taiwan, ChinaHealth Data Research Center, National Taiwan University
Jan 3, 2023
Periapical; Infection Trial in Irbid (Endodontic Microsurgery)
Recruiting
- Periapical; Infection
- Endodontic Microsurgery
-
Irbid, Jordan
- +1 more
Sep 4, 2023
Pain Postoperative, Swelling Lips & Face Trial in Irbid (Endodontic Microsurgery)
Recruiting
- Pain Postoperative
- Swelling Lips & Face
- Endodontic Microsurgery
-
Irbid, JordanJordan University of Science and Technology
Jun 7, 2023
Prescription Pattern Trial in Copenhagen (asthma education, Other education)
Recruiting
- Prescription Pattern
- asthma education
- Other education
-
Copenhagen, Capital Region Of Denmark, DenmarkUniversity Hospital Bispebjerg and Frederiksberg
Jun 29, 2022